The article presents the current state of knowledge on genetic modifiers of ovarian cancer risk in women carrying pathogenic variants (PVs) in the <i>BRCA1</i> and <i>BRCA2</i> genes, which are major contributors to hereditary susceptibility to this malignancy. The gene discussed is BRCA2; the disease is ovarian carcinoma.